Neonatal exendin-4 treatment also improves insulin secretion and glucose tolerance in adolescent and adult rat progeny following IUGR, preventing development of diabetes in these animals [15], although the effects during treatment were not measured in the latter study. Here, INS is linked to fetal growth restriction.